Serveur d'exploration H2N2

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Pandemic Paradox: Early Life H2N2 Pandemic Influenza Infection Enhanced Susceptibility to Death during the 2009 H1N1 Pandemic.

Identifieur interne : 000024 ( PubMed/Curation ); précédent : 000023; suivant : 000025

Pandemic Paradox: Early Life H2N2 Pandemic Influenza Infection Enhanced Susceptibility to Death during the 2009 H1N1 Pandemic.

Auteurs : Alain Gagnon [Canada] ; Enrique Acosta [Canada] ; Stacey Hallman [Canada] ; Robert Bourbeau [Canada] ; Lisa Y. Dillon [Canada] ; Nadine Ouellette [Canada] ; David J D. Earn [Canada] ; D Ann Herring [Canada] ; Kris Inwood [Canada] ; Joaquin Madrenas [États-Unis] ; Matthew S. Miller [Canada]

Source :

RBID : pubmed:29339427

Descripteurs français

English descriptors

Abstract

Recent outbreaks of H5, H7, and H9 influenza A viruses in humans have served as a vivid reminder of the potentially devastating effects that a novel pandemic could exert on the modern world. Those who have survived infections with influenza viruses in the past have been protected from subsequent antigenically similar pandemics through adaptive immunity. For example, during the 2009 H1N1 "swine flu" pandemic, those exposed to H1N1 viruses that circulated between 1918 and the 1940s were at a decreased risk for mortality as a result of their previous immunity. It is also generally thought that past exposures to antigenically dissimilar strains of influenza virus may also be beneficial due to cross-reactive cellular immunity. However, cohorts born during prior heterosubtypic pandemics have previously experienced elevated risk of death relative to surrounding cohorts of the same population. Indeed, individuals born during the 1890 H3Nx pandemic experienced the highest levels of excess mortality during the 1918 "Spanish flu." Applying Serfling models to monthly mortality and influenza circulation data between October 1997 and July 2014 in the United States and Mexico, we show corresponding peaks in excess mortality during the 2009 H1N1 "swine flu" pandemic and during the resurgent 2013-2014 H1N1 outbreak for those born at the time of the 1957 H2N2 "Asian flu" pandemic. We suggest that the phenomenon observed in 1918 is not unique and points to exposure to pandemic influenza early in life as a risk factor for mortality during subsequent heterosubtypic pandemics.IMPORTANCE The relatively low mortality experienced by older individuals during the 2009 H1N1 influenza virus pandemic has been well documented. However, reported situations in which previous influenza virus exposures have enhanced susceptibility are rare and poorly understood. One such instance occurred in 1918-when those born during the heterosubtypic 1890 H3Nx influenza virus pandemic experienced the highest levels of excess mortality. Here, we demonstrate that this phenomenon was not unique to the 1918 H1N1 pandemic but that it also occurred during the contemporary 2009 H1N1 pandemic and 2013-2014 H1N1-dominated season for those born during the heterosubtypic 1957 H2N2 "Asian flu" pandemic. These data highlight the heretofore underappreciated phenomenon that, in certain instances, prior exposure to pandemic influenza virus strains can enhance susceptibility during subsequent pandemics. These results have important implications for pandemic risk assessment and should inform laboratory studies aimed at uncovering the mechanism responsible for this effect.

DOI: 10.1128/mBio.02091-17
PubMed: 29339427

Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:29339427

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Pandemic Paradox: Early Life H2N2 Pandemic Influenza Infection Enhanced Susceptibility to Death during the 2009 H1N1 Pandemic.</title>
<author>
<name sortKey="Gagnon, Alain" sort="Gagnon, Alain" uniqKey="Gagnon A" first="Alain" last="Gagnon">Alain Gagnon</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Demography, Université de Montréal, Montréal, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Department of Demography, Université de Montréal, Montréal</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Acosta, Enrique" sort="Acosta, Enrique" uniqKey="Acosta E" first="Enrique" last="Acosta">Enrique Acosta</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Demography, Université de Montréal, Montréal, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Department of Demography, Université de Montréal, Montréal</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Hallman, Stacey" sort="Hallman, Stacey" uniqKey="Hallman S" first="Stacey" last="Hallman">Stacey Hallman</name>
<affiliation wicri:level="1">
<nlm:affiliation>Statistics Canada, Ottawa, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Statistics Canada, Ottawa</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Bourbeau, Robert" sort="Bourbeau, Robert" uniqKey="Bourbeau R" first="Robert" last="Bourbeau">Robert Bourbeau</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Demography, Université de Montréal, Montréal, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Department of Demography, Université de Montréal, Montréal</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Dillon, Lisa Y" sort="Dillon, Lisa Y" uniqKey="Dillon L" first="Lisa Y" last="Dillon">Lisa Y. Dillon</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Demography, Université de Montréal, Montréal, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Department of Demography, Université de Montréal, Montréal</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Ouellette, Nadine" sort="Ouellette, Nadine" uniqKey="Ouellette N" first="Nadine" last="Ouellette">Nadine Ouellette</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Demography, Université de Montréal, Montréal, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Department of Demography, Université de Montréal, Montréal</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Earn, David J D" sort="Earn, David J D" uniqKey="Earn D" first="David J D" last="Earn">David J D. Earn</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Mathematics and Statistics, McMaster University, Hamilton, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Department of Mathematics and Statistics, McMaster University, Hamilton</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Herring, D Ann" sort="Herring, D Ann" uniqKey="Herring D" first="D Ann" last="Herring">D Ann Herring</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Anthropology, McMaster University, Hamilton, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Department of Anthropology, McMaster University, Hamilton</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Inwood, Kris" sort="Inwood, Kris" uniqKey="Inwood K" first="Kris" last="Inwood">Kris Inwood</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Economics and Finance, Department of History, University of Guelph, Guelph, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Department of Economics and Finance, Department of History, University of Guelph, Guelph</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Madrenas, Joaquin" sort="Madrenas, Joaquin" uniqKey="Madrenas J" first="Joaquin" last="Madrenas">Joaquin Madrenas</name>
<affiliation wicri:level="1">
<nlm:affiliation>Los Angeles Biomedical Research Institute at Harbor, UCLA Medical Center, Los Angeles, California, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Los Angeles Biomedical Research Institute at Harbor, UCLA Medical Center, Los Angeles, California</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Miller, Matthew S" sort="Miller, Matthew S" uniqKey="Miller M" first="Matthew S" last="Miller">Matthew S. Miller</name>
<affiliation wicri:level="1">
<nlm:affiliation>Michael G. DeGroote Institute for Infectious Diseases Research, McMaster University, Hamilton, Canada mmiller@mcmaster.ca.</nlm:affiliation>
<country wicri:rule="url">Canada</country>
<wicri:regionArea>Michael G. DeGroote Institute for Infectious Diseases Research, McMaster University, Hamilton</wicri:regionArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2018">2018</date>
<idno type="RBID">pubmed:29339427</idno>
<idno type="pmid">29339427</idno>
<idno type="doi">10.1128/mBio.02091-17</idno>
<idno type="wicri:Area/PubMed/Corpus">000024</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000024</idno>
<idno type="wicri:Area/PubMed/Curation">000024</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000024</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Pandemic Paradox: Early Life H2N2 Pandemic Influenza Infection Enhanced Susceptibility to Death during the 2009 H1N1 Pandemic.</title>
<author>
<name sortKey="Gagnon, Alain" sort="Gagnon, Alain" uniqKey="Gagnon A" first="Alain" last="Gagnon">Alain Gagnon</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Demography, Université de Montréal, Montréal, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Department of Demography, Université de Montréal, Montréal</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Acosta, Enrique" sort="Acosta, Enrique" uniqKey="Acosta E" first="Enrique" last="Acosta">Enrique Acosta</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Demography, Université de Montréal, Montréal, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Department of Demography, Université de Montréal, Montréal</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Hallman, Stacey" sort="Hallman, Stacey" uniqKey="Hallman S" first="Stacey" last="Hallman">Stacey Hallman</name>
<affiliation wicri:level="1">
<nlm:affiliation>Statistics Canada, Ottawa, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Statistics Canada, Ottawa</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Bourbeau, Robert" sort="Bourbeau, Robert" uniqKey="Bourbeau R" first="Robert" last="Bourbeau">Robert Bourbeau</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Demography, Université de Montréal, Montréal, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Department of Demography, Université de Montréal, Montréal</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Dillon, Lisa Y" sort="Dillon, Lisa Y" uniqKey="Dillon L" first="Lisa Y" last="Dillon">Lisa Y. Dillon</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Demography, Université de Montréal, Montréal, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Department of Demography, Université de Montréal, Montréal</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Ouellette, Nadine" sort="Ouellette, Nadine" uniqKey="Ouellette N" first="Nadine" last="Ouellette">Nadine Ouellette</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Demography, Université de Montréal, Montréal, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Department of Demography, Université de Montréal, Montréal</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Earn, David J D" sort="Earn, David J D" uniqKey="Earn D" first="David J D" last="Earn">David J D. Earn</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Mathematics and Statistics, McMaster University, Hamilton, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Department of Mathematics and Statistics, McMaster University, Hamilton</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Herring, D Ann" sort="Herring, D Ann" uniqKey="Herring D" first="D Ann" last="Herring">D Ann Herring</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Anthropology, McMaster University, Hamilton, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Department of Anthropology, McMaster University, Hamilton</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Inwood, Kris" sort="Inwood, Kris" uniqKey="Inwood K" first="Kris" last="Inwood">Kris Inwood</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Economics and Finance, Department of History, University of Guelph, Guelph, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Department of Economics and Finance, Department of History, University of Guelph, Guelph</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Madrenas, Joaquin" sort="Madrenas, Joaquin" uniqKey="Madrenas J" first="Joaquin" last="Madrenas">Joaquin Madrenas</name>
<affiliation wicri:level="1">
<nlm:affiliation>Los Angeles Biomedical Research Institute at Harbor, UCLA Medical Center, Los Angeles, California, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Los Angeles Biomedical Research Institute at Harbor, UCLA Medical Center, Los Angeles, California</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Miller, Matthew S" sort="Miller, Matthew S" uniqKey="Miller M" first="Matthew S" last="Miller">Matthew S. Miller</name>
<affiliation wicri:level="1">
<nlm:affiliation>Michael G. DeGroote Institute for Infectious Diseases Research, McMaster University, Hamilton, Canada mmiller@mcmaster.ca.</nlm:affiliation>
<country wicri:rule="url">Canada</country>
<wicri:regionArea>Michael G. DeGroote Institute for Infectious Diseases Research, McMaster University, Hamilton</wicri:regionArea>
</affiliation>
</author>
</analytic>
<series>
<title level="j">mBio</title>
<idno type="eISSN">2150-7511</idno>
<imprint>
<date when="2018" type="published">2018</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Disease Susceptibility</term>
<term>Humans</term>
<term>Influenza A Virus, H1N1 Subtype (immunology)</term>
<term>Influenza A Virus, H2N2 Subtype (immunology)</term>
<term>Influenza, Human (immunology)</term>
<term>Influenza, Human (mortality)</term>
<term>Influenza, Human (virology)</term>
<term>Mexico (epidemiology)</term>
<term>Risk Factors</term>
<term>United States (epidemiology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Facteurs de risque</term>
<term>Grippe humaine (immunologie)</term>
<term>Grippe humaine (mortalité)</term>
<term>Grippe humaine (virologie)</term>
<term>Humains</term>
<term>Mexique (épidémiologie)</term>
<term>Sous-type H1N1 du virus de la grippe A (immunologie)</term>
<term>Sous-type H2N2 du virus de la grippe A (immunologie)</term>
<term>Susceptibilité à une maladie</term>
<term>États-Unis d'Amérique (épidémiologie)</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en">
<term>Mexico</term>
<term>United States</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr">
<term>Grippe humaine</term>
<term>Sous-type H1N1 du virus de la grippe A</term>
<term>Sous-type H2N2 du virus de la grippe A</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en">
<term>Influenza A Virus, H1N1 Subtype</term>
<term>Influenza A Virus, H2N2 Subtype</term>
<term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="mortality" xml:lang="en">
<term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="mortalité" xml:lang="fr">
<term>Grippe humaine</term>
</keywords>
<keywords scheme="MESH" qualifier="virologie" xml:lang="fr">
<term>Grippe humaine</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en">
<term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr">
<term>Mexique</term>
<term>États-Unis d'Amérique</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Disease Susceptibility</term>
<term>Humans</term>
<term>Risk Factors</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Facteurs de risque</term>
<term>Humains</term>
<term>Susceptibilité à une maladie</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Recent outbreaks of H5, H7, and H9 influenza A viruses in humans have served as a vivid reminder of the potentially devastating effects that a novel pandemic could exert on the modern world. Those who have survived infections with influenza viruses in the past have been protected from subsequent antigenically similar pandemics through adaptive immunity. For example, during the 2009 H1N1 "swine flu" pandemic, those exposed to H1N1 viruses that circulated between 1918 and the 1940s were at a decreased risk for mortality as a result of their previous immunity. It is also generally thought that past exposures to antigenically dissimilar strains of influenza virus may also be beneficial due to cross-reactive cellular immunity. However, cohorts born during prior heterosubtypic pandemics have previously experienced elevated risk of death relative to surrounding cohorts of the same population. Indeed, individuals born during the 1890 H3Nx pandemic experienced the highest levels of excess mortality during the 1918 "Spanish flu." Applying Serfling models to monthly mortality and influenza circulation data between October 1997 and July 2014 in the United States and Mexico, we show corresponding peaks in excess mortality during the 2009 H1N1 "swine flu" pandemic and during the resurgent 2013-2014 H1N1 outbreak for those born at the time of the 1957 H2N2 "Asian flu" pandemic. We suggest that the phenomenon observed in 1918 is not unique and points to exposure to pandemic influenza early in life as a risk factor for mortality during subsequent heterosubtypic pandemics.
<b>IMPORTANCE</b>
The relatively low mortality experienced by older individuals during the 2009 H1N1 influenza virus pandemic has been well documented. However, reported situations in which previous influenza virus exposures have enhanced susceptibility are rare and poorly understood. One such instance occurred in 1918-when those born during the heterosubtypic 1890 H3Nx influenza virus pandemic experienced the highest levels of excess mortality. Here, we demonstrate that this phenomenon was not unique to the 1918 H1N1 pandemic but that it also occurred during the contemporary 2009 H1N1 pandemic and 2013-2014 H1N1-dominated season for those born during the heterosubtypic 1957 H2N2 "Asian flu" pandemic. These data highlight the heretofore underappreciated phenomenon that, in certain instances, prior exposure to pandemic influenza virus strains can enhance susceptibility during subsequent pandemics. These results have important implications for pandemic risk assessment and should inform laboratory studies aimed at uncovering the mechanism responsible for this effect.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">29339427</PMID>
<DateCompleted>
<Year>2018</Year>
<Month>12</Month>
<Day>11</Day>
</DateCompleted>
<DateRevised>
<Year>2019</Year>
<Month>12</Month>
<Day>27</Day>
</DateRevised>
<Article PubModel="Electronic">
<Journal>
<ISSN IssnType="Electronic">2150-7511</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>9</Volume>
<Issue>1</Issue>
<PubDate>
<Year>2018</Year>
<Month>01</Month>
<Day>16</Day>
</PubDate>
</JournalIssue>
<Title>mBio</Title>
<ISOAbbreviation>mBio</ISOAbbreviation>
</Journal>
<ArticleTitle>Pandemic Paradox: Early Life H2N2 Pandemic Influenza Infection Enhanced Susceptibility to Death during the 2009 H1N1 Pandemic.</ArticleTitle>
<ELocationID EIdType="pii" ValidYN="Y">e02091-17</ELocationID>
<ELocationID EIdType="doi" ValidYN="Y">10.1128/mBio.02091-17</ELocationID>
<Abstract>
<AbstractText>Recent outbreaks of H5, H7, and H9 influenza A viruses in humans have served as a vivid reminder of the potentially devastating effects that a novel pandemic could exert on the modern world. Those who have survived infections with influenza viruses in the past have been protected from subsequent antigenically similar pandemics through adaptive immunity. For example, during the 2009 H1N1 "swine flu" pandemic, those exposed to H1N1 viruses that circulated between 1918 and the 1940s were at a decreased risk for mortality as a result of their previous immunity. It is also generally thought that past exposures to antigenically dissimilar strains of influenza virus may also be beneficial due to cross-reactive cellular immunity. However, cohorts born during prior heterosubtypic pandemics have previously experienced elevated risk of death relative to surrounding cohorts of the same population. Indeed, individuals born during the 1890 H3Nx pandemic experienced the highest levels of excess mortality during the 1918 "Spanish flu." Applying Serfling models to monthly mortality and influenza circulation data between October 1997 and July 2014 in the United States and Mexico, we show corresponding peaks in excess mortality during the 2009 H1N1 "swine flu" pandemic and during the resurgent 2013-2014 H1N1 outbreak for those born at the time of the 1957 H2N2 "Asian flu" pandemic. We suggest that the phenomenon observed in 1918 is not unique and points to exposure to pandemic influenza early in life as a risk factor for mortality during subsequent heterosubtypic pandemics.
<b>IMPORTANCE</b>
The relatively low mortality experienced by older individuals during the 2009 H1N1 influenza virus pandemic has been well documented. However, reported situations in which previous influenza virus exposures have enhanced susceptibility are rare and poorly understood. One such instance occurred in 1918-when those born during the heterosubtypic 1890 H3Nx influenza virus pandemic experienced the highest levels of excess mortality. Here, we demonstrate that this phenomenon was not unique to the 1918 H1N1 pandemic but that it also occurred during the contemporary 2009 H1N1 pandemic and 2013-2014 H1N1-dominated season for those born during the heterosubtypic 1957 H2N2 "Asian flu" pandemic. These data highlight the heretofore underappreciated phenomenon that, in certain instances, prior exposure to pandemic influenza virus strains can enhance susceptibility during subsequent pandemics. These results have important implications for pandemic risk assessment and should inform laboratory studies aimed at uncovering the mechanism responsible for this effect.</AbstractText>
<CopyrightInformation>Copyright © 2018 Gagnon et al.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y" EqualContrib="Y">
<LastName>Gagnon</LastName>
<ForeName>Alain</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Demography, Université de Montréal, Montréal, Canada.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Université de Montréal Public Health Research Institute (IRSPUM), Montréal, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y" EqualContrib="Y">
<LastName>Acosta</LastName>
<ForeName>Enrique</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>Department of Demography, Université de Montréal, Montréal, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hallman</LastName>
<ForeName>Stacey</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Statistics Canada, Ottawa, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bourbeau</LastName>
<ForeName>Robert</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Department of Demography, Université de Montréal, Montréal, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Dillon</LastName>
<ForeName>Lisa Y</ForeName>
<Initials>LY</Initials>
<AffiliationInfo>
<Affiliation>Department of Demography, Université de Montréal, Montréal, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ouellette</LastName>
<ForeName>Nadine</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>Department of Demography, Université de Montréal, Montréal, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Earn</LastName>
<ForeName>David J D</ForeName>
<Initials>DJD</Initials>
<AffiliationInfo>
<Affiliation>Department of Mathematics and Statistics, McMaster University, Hamilton, Canada.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Michael G. DeGroote Institute for Infectious Diseases Research, McMaster University, Hamilton, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Herring</LastName>
<ForeName>D Ann</ForeName>
<Initials>DA</Initials>
<AffiliationInfo>
<Affiliation>Department of Anthropology, McMaster University, Hamilton, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Inwood</LastName>
<ForeName>Kris</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Department of Economics and Finance, Department of History, University of Guelph, Guelph, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Madrenas</LastName>
<ForeName>Joaquin</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Los Angeles Biomedical Research Institute at Harbor, UCLA Medical Center, Los Angeles, California, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y" EqualContrib="Y">
<LastName>Miller</LastName>
<ForeName>Matthew S</ForeName>
<Initials>MS</Initials>
<AffiliationInfo>
<Affiliation>Michael G. DeGroote Institute for Infectious Diseases Research, McMaster University, Hamilton, Canada mmiller@mcmaster.ca.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Department of Biochemistry and Biomedical Sciences, McMaster Immunology Research Centre, McMaster University, Hamilton, Canada.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<Agency>CIHR</Agency>
<Country>Canada</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2018</Year>
<Month>01</Month>
<Day>16</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>mBio</MedlineTA>
<NlmUniqueID>101519231</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D004198" MajorTopicYN="Y">Disease Susceptibility</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D053118" MajorTopicYN="N">Influenza A Virus, H1N1 Subtype</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D053121" MajorTopicYN="N">Influenza A Virus, H2N2 Subtype</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
<QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008800" MajorTopicYN="N">Mexico</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D014481" MajorTopicYN="N">United States</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="Y">influenza virus</Keyword>
<Keyword MajorTopicYN="Y">mortality</Keyword>
<Keyword MajorTopicYN="Y">pandemics</Keyword>
<Keyword MajorTopicYN="Y">susceptibility</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="entrez">
<Year>2018</Year>
<Month>1</Month>
<Day>18</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2018</Year>
<Month>1</Month>
<Day>18</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2018</Year>
<Month>12</Month>
<Day>12</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">29339427</ArticleId>
<ArticleId IdType="pii">mBio.02091-17</ArticleId>
<ArticleId IdType="doi">10.1128/mBio.02091-17</ArticleId>
<ArticleId IdType="pmc">PMC5770550</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>Curr Opin Virol. 2017 Feb;22:105-111</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28088686</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Sci Transl Med. 2013 Aug 14;5(198):198ra107</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23946196</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2013 Aug 05;8(8):e69586</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23940526</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Science. 2016 Nov 11;354(6313):722-726</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27846599</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2013 May 22;8(5):e64198</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23717567</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Emerg Infect Dis. 2012 Feb;18(2):201-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22306191</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2011;6(12):e29301</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22206008</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2014 Sep 9;111(36):13133-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25157133</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Bull World Health Organ. 1999;77(10):820-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10593030</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Vaccine. 2010 Jul 12;28(31):4895-902</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20553769</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Infect Dis. 2011 Jan 1;52 Suppl 1:S75-82</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21342903</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS Med. 2013 Nov;10(11):e1001558</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24302890</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Vaccine. 2007 Jun 28;25(27):5086-96</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17544181</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2012;7(9):e45051</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23028756</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2014 Jun 3;111(22):8107-12</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24778238</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell. 2014 Apr 10;157(2):294-299</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24725400</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Exp Med. 2013 Jul 29;210(8):1493-500</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23857983</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect Dis. 2013 Jan 1;207(1):98-105</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23087428</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Euro Surveill. 2010 Feb 04;15(5):null</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20144443</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Public Health Rep. 2010 Apr;125 Suppl 3:16-26</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20568566</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2014 Nov 4;111(44):15798-803</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25331901</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ann Intern Med. 2012 Feb 7;156(3):173-81</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22312137</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2009 Oct 30;4(10):e7671</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19876396</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMC Infect Dis. 2014 Dec 11;14:670</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25495228</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Rev Drug Discov. 2015 Mar;14(3):167-82</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25722244</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Infect Dis. 2011 Dec;53(12):1179-87</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21976461</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Science. 2009 Jul 10;325(5937):197-201</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19465683</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2014 Nov;88(22):13260-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25210189</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Emerg Infect Dis. 2006 Jan;12(1):9-14</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16494710</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Public Health Rep. 1963 Jun;78(6):494-506</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19316455</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS Pathog. 2015 Mar 05;11(3):e1004615</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25742615</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arch Med Res. 2012 Oct;43(7):563-70</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23079035</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2012;7(10):e48187</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23118949</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Theor Biol. 2011 Nov 7;288:29-34</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21856313</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS Med. 2008 Mar 25;5(3):e74</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18366252</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Expert Rev Vaccines. 2013 May;12(5):519-36</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23659300</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Influenza Other Respir Viruses. 2013 Sep;7(5):872-86</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23331969</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2012;7(8):e42328</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22876316</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arch Med Res. 2015 Jan;46(1):63-70</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25446618</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Infect Dis. 2013 Jul;57 Suppl 1:S23-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23794728</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Infect Dis. 2010 Jun 1;50(11):1487-92</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20415539</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>JAMA. 2003 Jan 8;289(2):179-86</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12517228</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Influenza Other Respir Viruses. 2009 Jan;3(1):37-49</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19453440</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2013;8(1):e54015</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23326561</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2009 Nov 12;361(20):2000-1</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19907052</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Sci Transl Med. 2013 May 29;5(187):187ra70</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23720581</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000024 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 000024 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    H2N2V1
   |flux=    PubMed
   |étape=   Curation
   |type=    RBID
   |clé=     pubmed:29339427
   |texte=   Pandemic Paradox: Early Life H2N2 Pandemic Influenza Infection Enhanced Susceptibility to Death during the 2009 H1N1 Pandemic.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i   -Sk "pubmed:29339427" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a H2N2V1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 14 19:59:40 2020. Site generation: Thu Mar 25 15:38:26 2021